Search details
1.
Seven-plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi-Institutional Collaborative Cohort Study.
Cancer Sci
; 115(2): 611-622, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38041484
2.
Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy.
Biol Pharm Bull
; 46(7): 964-968, 2023.
Article
in English
| MEDLINE | ID: mdl-37394646
3.
[A Case of Aortitis Caused by Pegfilgrastim Use during Neoadjuvant Chemotherapy for Treating Breast Cancer].
Gan To Kagaku Ryoho
; 49(5): 573-576, 2022 May.
Article
in Japanese
| MEDLINE | ID: mdl-35578937
4.
The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results.
J Bone Miner Metab
; 39(2): 224-229, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-32889575
5.
[A Case of Synchronous Bilateral Male Breast Cancer].
Gan To Kagaku Ryoho
; 47(6): 973-976, 2020 Jun.
Article
in Japanese
| MEDLINE | ID: mdl-32541177
6.
[A Case of Small Cell Carcinoma of the Breast].
Gan To Kagaku Ryoho
; 46(12): 1891-1893, 2019 Dec.
Article
in Japanese
| MEDLINE | ID: mdl-31879410
7.
[Experience of Fulvestrant for Hormone Receptor-Positive HER2-Negative Advanced and Metastatic Breast Cancer].
Gan To Kagaku Ryoho
; 45(6): 949-954, 2018 Jun.
Article
in Japanese
| MEDLINE | ID: mdl-30026420
9.
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues.
Breast Cancer
; 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38587783
10.
Concise synthesis of heterocycle-fused naphthoquinones by employing sonogashira coupling and tandem addition-elimination/intramolecular cyclization.
Chem Pharm Bull (Tokyo)
; 61(6): 648-54, 2013.
Article
in English
| MEDLINE | ID: mdl-23727778
11.
Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen.
Cancer Chemother Pharmacol
; 91(1): 25-31, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36401659
12.
Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer.
Cancer Treat Res Commun
; 36: 100711, 2023.
Article
in English
| MEDLINE | ID: mdl-37245351
13.
Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib.
Anticancer Res
; 43(6): 2783-2789, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37247903
14.
Myoid hamartoma of the breast that proved difficult to diagnose: a case report.
World J Surg Oncol
; 10: 12, 2012 Jan 16.
Article
in English
| MEDLINE | ID: mdl-22248347
15.
Low-cost high-speed imaging system for observing vocal fold vibration in voice disorders.
ORL J Otorhinolaryngol Relat Spec
; 74(4): 208-10, 2012.
Article
in English
| MEDLINE | ID: mdl-22868889
16.
[A case of breast cancer with brain metastases responding to paclitaxel and capecitabine therapy].
Gan To Kagaku Ryoho
; 39(2): 261-3, 2012 Feb.
Article
in Japanese
| MEDLINE | ID: mdl-22333639
17.
[Administration of nab-paclitaxel for 9 metastatic breast cancer patients].
Gan To Kagaku Ryoho
; 39(7): 1081-5, 2012 Jul.
Article
in Japanese
| MEDLINE | ID: mdl-22790043
18.
[A case of effective lapatinib/capecitabine therapy for HER2-positive breast cancer with multiple brain metastases].
Gan To Kagaku Ryoho
; 39(11): 1699-702, 2012 Nov.
Article
in Japanese
| MEDLINE | ID: mdl-23152022
19.
Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trial.
Med Oncol
; 39(10): 153, 2022 Jul 19.
Article
in English
| MEDLINE | ID: mdl-35852641
20.
One-pot synthesis of benzo[f]indole-4,9-diones from 1,4-naphthoquinones and terminal acetylenes.
Chem Pharm Bull (Tokyo)
; 59(10): 1289-93, 2011.
Article
in English
| MEDLINE | ID: mdl-21963641